2007 Honda Accord Ex-l Sedan Auto Htd Leather Sunroof Texas Direct Auto on 2040-cars

Auto blog

Honda Fit, Vezel Hybrids recalled in Japan; US vehicles not affected

Honda has announced a good-sized recall of two popular Japanese-market hybrids: the Fit Hybrid and the Vezel Hybrid are both headed back into the garage. The problem this time around lies in the software program that controls the 7-speed dual clutch transmission (DCT) that could "cause a delay in the ability to begin driving or the inability to move at all." In total, 81,353 units are affected (70,929 Fit Hybrids and 10,424 Vezel Hybrids) and all were made in Japan between July 2013 and February 2014. There were two previous recalls for the new Fit Hybrid's DCT, and you can find the details of them below. Jessica Fini, assistant manager of PR for Honda North America, told AutoblogGreen that this recall will not have any impact on US Honda vehicles. For one thing, the US Fit has a continuously variable transmission (CVT) instead of a DCT, so the upcoming launch of the new Fit here (the US doesn't get the Fit Hybrid) will not be delayed. Honda's upcoming small SUV in the US (based on the Vezel, but will arrive with a different name) isn't going to launch here until the end of the year, so there is time to fix any problems before launch. She also said that the Acura RLX, despite being a DCT, does not use the same transmission as the Fit Hybrid does, since the Fit transmission is specific to the one-motor hybrid system and the RLX uses three electric motors. Recall of All-New Fit Hybrid and Vezel Hybrid ref. # C14-009 TOKYO -- February 10, 2014 – Honda Motor Co., Ltd. today announced a voluntary recall of the all-new Fit Hybrid and Vezel Hybrid produced in Japan from July 2013 through February 2014 due to a problem with the software program controlling the 7-speed dual clutch transmission (DCT) which could cause a delay in the ability to begin driving or the inability to move at all. Honda today notified the Ministry of Land, Infrastructure, Transport and Tourism of the recall with a total recall population of 81,353 units. Honda conducted two recalls in October and December 2013 due to a defect with the software program controlling the 7-speed DCT which could have caused a delay in the ability to drive the vehicle or the inability to drive. This will be the third recall related to the defect of the 7-speed DCT.

Honda working with new supplier Autoliv for Takata inflator recall

Takata is fighting against US regulators over whether to expand its airbag inflator recall nationwide, but the affected automakers are continuing to broaden their own campaigns to get these vehicles fixed. Honda is the first company to take the bold move of partnering with another supplier for its replacement parts. It just announced plans to work with Autoliv to create components for models needing repaired in the US. "The agreement is made in order to meet the expanded supply of inflators needed by Honda and is subject to definitive documentation," Autoliv said in a statement. The company plans to add the extra capacity for these replacement parts at its existing factories, and deliveries are expected to begin in six months. The decision to switch suppliers was quite surprising because the choice was largely considered impractical previously. Automakers believed that changing manufacturers could take as long as a year or more to implement. However, Autoliv apparently found a way to accelerate that. According to Reuters, Honda said at a hearing in the House of Representatives on December 3 (pictured above) that it was in talks with Autoliv and another supplier called Daicel about building more inflators. The extra parts are sure to come in handy for Honda, as it is now officially expanding its driver side inflator recall nationwide. Although, that that option was already available to any concerned drivers who asked for the remedy. Even with added capacity, Takata had estimated it would take two years to manufacturer enough replacements to fix all of the affected vehicles from all of the automakers. Scroll down to read Autoliv's statement on its new role. Autoliv to supply replacement airbag inflators to be used by Honda (Stockholm, December 3, 2014) – – – Autoliv, Inc. (NYSE: ALV, and SSE: ALIV sdb), the worldwide leader in automotive safety, will supply replacement airbag inflators to be used by Honda Motor Company in support of the ongoing field action initiatives in the United States. The agreement is made in order to meet the expanded supply of inflators needed by Honda and is subject to definitive documentation. In order to be able to meet increased demand, Autoliv will build additional inflator capacity in its existing manufacturing facilities. Deliveries are estimated to commence after a period of about six months from today.

Honda, Hyundai and Kia get best word-of-mouth recommendations in US

Forget advertising, incentives and, yes, even our excellently crafted vehicle reviews, sometimes the best way for automakers to sell cars is still good ol' fashioned word of mouth. In an attempt to measure this "word of mouth" power, The Boston Consulting Group, a management consulting firm, has created a new study called the Brand Advocacy Index (BAI). The index takes a look at how various industries perform from person to person. Those industries include automotive, smartphones, grocery, mobile telecommunications and banking.
The study polled more than 32,000 individuals across Europe and in the US to come up with the top 55 brands in these various industries. On the automotive side of things, the top brands in the US were Honda, Hyundai and Kia, all tied at 63 percent. On a global scale, Volkswagen and Toyota scored the highest with a 65-percent BAI rating (both in France). The average BAI for auto industry players tallied 50 percent.
As for companies in other industries, Apple's iPhone was the index's top-rated smartphone, Trader Joe's was the highest recommended grocery store, Virgin was sat atop the mobile telecom industry and USAA was the top retail bank. Scroll down for the full press release on the new study.